Structure-based approaches to inhibition of erbB receptors with peptide mimetics

Author： Berezov Alan   Greene Mark   Murali Ramachandran  

Publisher： Humana Press, Inc

ISSN： 0257-277X

Source： Immunologic Research, Vol.27, Iss.2-3, 2003-06, pp. : 303-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The ErbB receptor family: a therapeutic target for cancer

By de Bono J.S.   Rowinsky E.K.  

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 19-26

Elsevier

Access to resources Recommend Favorite

Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 11, Iss. 2, 2011-06 ,pp. : 131-149

Bentham Science Publishers

Access to resources Recommend Favorite

Cooperating Oncogenic Events in Murine Mammary Tumorigenesis: Assessment of ErbB2, Mutant p53, and Mouse Mammary Tumor Virus

By Zelazny E.   Li B.   Anagnostopoulos A.-M.   Coleman A.   Perkins A.S.  

Experimental and Molecular Pathology, Vol. 70, Iss. 3, 2001-06 ,pp. : 183-193

Elsevier

Access to resources Recommend Favorite

Formyl-peptide receptors revisited

By Le Y.   Murphy P.M.   Wang J.M.  

Trends in Immunology, Vol. 23, Iss. 11, 2002-11 ,pp. : 541-548

Elsevier

Access to resources Recommend Favorite

A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements

By Kimura Mikihiko  

Virchows Archiv, Vol. 445, Iss. 3, 2004-09 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite